80th European Atherosclerosis Society Congress
Webcasted Presentations

Search’n Build™

This programme was EBAC Accredited during EAS 2012, however no CME credits will be provided for viewing this webcast.
Intoduction to the Anitschkow lecture
by John Chapman
2012-05-25 2 minutes  
A BRIEF HISTORY OF CHOLESTEROL LOWERING
by Terje R Pedersen
2012-05-25 32 minutes  
This programme was EBAC Accredited during EAS 2012, however no CME credits will be provided for viewing this webcast.
BUILDING A VESSEL WALL: FROM DEVELOPMENTAL BIOLOGY TO PHYSIOLOGICAL AND PATHO...
by Mark Majesky
2012-05-26 33 minutes    
ENDOTHELIAL FUNCTION AND DYSFUNCTION: THE KEYS TO CORONARY AND PERIPHERAL CIR...
by Ulf Landmesser
2012-05-26 23 minutes  
IMMUNITY IN ATHEROSCLEROSIS
by Goran Hansson
2012-05-26 26 minutes  
UNDERSTANDING THE VULNERABLE PLAQUE – BASIS FOR TREATMENT OPTIONS
by Gerard Pasterkamp
2012-05-26 22 minutes  
EBAC-Accredited Educational Programme supported by an unrestricted grant from AstraZeneca. This programme was EBAC Accredited during EAS 2012, however no CME credits will be provided for viewing this webcast.
Opening remarks (Chair 1)
by Alberico L. Catapano
2012-05-26  
Further reducing cardiovascular risk – what to target?
by Julian Halcox
2012-05-26 26 minutes  
Treatment challenges in patients with familial hypercholesterolaemia
by Marcello Arca
2012-05-26 15 minutes  
Improving patient management – how implementation of the latest guidelines wi...
by Lale Tokgozoglu
2012-05-26 16 minutes  
Closing remarks (Chair 2)
by Terje R Pedersen
2012-05-26 4 minutes  
 
This programme was EBAC Accredited during EAS 2012, however no CME credits will be provided for viewing this webcast.
THE MACROPHAGE LIPOPROTEIN INTERACTIONS – FOR GOOD OR FOR BAD
by Miranda van Eck
2012-05-27 26 minutes  
NOVEL ANTI-ATHEROGENIC MECHANISMS OF HDL AND ABC TRANSPORTERS
by Alan Tall
2012-05-27 15 minutes  
GENETICS OF ATHEROGENIC DYSLIPIDEMIAS
by Robert Hegele
2012-05-27 28 minutes  
ARE LIPOPROTEIN REMNANTS A REASONABLE TARGET FOR THERAPY?
by Henry Ginsberg
2012-05-27 27 minutes  
This programme was EBAC Accredited during EAS 2012, however no CME credits will be provided for viewing this webcast.
GENERAL TRENDS OF CARDIOVASCULAR DISEASE IN EUROPE AND RISK FACTORS IN SPECIA...
by Borge Nordestgaard
2012-05-28 24 minutes  
LIFESTYLE AND NUTRITIONAL STRATEGIES IN PREVENTING CARDIOVASCULAR DISEASE
by Aila Rissanen
2012-05-28 26 minutes  
NEW PERSPECTIVES IN HYPOLIPIDEMIC TREATMENT
by John J.P. Kastelein
2012-05-28 27 minutes  
ECONOMIC ISSUES IN CARDIOVASCULAR DISEASE: WHAT ARE THE COSTS OF PREVENTION?
by Giuseppe Mancia
2012-05-28 24 minutes  
This programme was EBAC Accredited during EAS 2012, however no CME credits will be provided for viewing this webcast.
CAN WE ENCOURAGE OUR HYPERCHOLESTEROLEMIC PATIENTS TO TAKE PLANT STEROL ENRIC...
by Eric Bruckert
2012-05-27 26 minutes  
 
Severe heterozygous familial hypercholesterolaemia and the potential role of antisense technology
Opening remarks
by Alberico L. Catapano
2012-05-26 5 minutes  
Risk factors in severe heterozygous FH
by Eric Bruckert
2012-05-26 21 minutes  
Metabolic regulation of apoB-containing lipoproteins in severe FH
by Gerald Watts
2012-05-26 25 minutes  
New treatment options in patients with severe heterozygous FH: applying antis...
by Christie M. Ballantyne
2012-05-26 15 minutes  
Panel Discussion
by Panel Discussion
2012-05-26 6 minutes  
 
Pitavastatin: New effective option for managing dyslipidaemia with diabetes or high cardiovascular risk
Opening remarks (Chair)
by Alberico L. Catapano
2012-05-27 4 minutes  
Managing dyslipidaemia complicated with diabetes or high cardiovascular risk:...
by John Betteridge
2012-05-27 25 minutes  
Pitavastatin for the management of dyslipidaemia and atherosclerosis
by José-Ramon Gonzalez -Juanatey
2012-05-27 25 minutes  
Pitavastatin: addressing challenges: JAPAN-ACS and CIRCLE studies
by Hidenori Arai
2012-05-27 16 minutes  
Panel Discussion
by Panel Discussion
2012-05-27 6 minutes